Unspecified Adult Solid Tumor, Protocol Specific — Pralatrexate and Fluorouracil in Treating Patients With Recurrent Solid Tumors
Citation(s)
A Phase I Clinical Trial of Sequential Pralatrexate Followed by a 48-hour Infusion of 5- Fluorouracil Given Every Other Week in Adult Patients With Solid Tumors